Xylo Technologies Ltd (XYLO) AI Stock Analysis

• Market Cap: $3.91M
• Dividend Yield: N/A
• Average Volume (3M): 2.39K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.44
• Revenue Growth: -67.77%
• EPS Growth: 66.19%
• Country: US
• Employees: 38
• Sector: Healthcare
• Sector Strength: 37
• Industry: Medical - Devices
• EPS (TTM): 2.66
• Shares Outstanding: 1,281,042
• 10 Day Avg. Volume: 1,285
• 30 Day Avg. Volume: 2,392
• PEG Ratio: <0.01
• Price to Book (P/B): 0.19
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -1.32
• Enterprise Value/Market Cap: -0.65
• Enterprise Value/Revenue: >-0.01
• Enterprise Value/Gross Profit: -0.32
• Enterprise Value/Ebitda: 0.10
• 1Y Price Target: $5.00
• Price Target Upside: 3.09% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 45 Neutral
• Price Target: $5.00 ▲(3.09%Upside)

Xylo Technologies Ltd faces considerable financial and operational challenges, with financial performance being the most significant factor. The negative valuation metrics and bearish technical indicators further contribute to the low score.

Xylo Technologies Ltd Business Overview & Revenue Model

Company Description

Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops wireless vehicle battery charging technologies and modular electronic vehicles. The company was formerly known as Medigus Ltd. and changed its name to Xylo Technologies Ltd in April 2024. Xylo Technologies Ltd was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.

How the Company Makes Money

Xylo Technologies Ltd generates revenue through a diversified portfolio of technology-driven services and products. The company's primary revenue streams include subscription-based software-as-a-service (SaaS) offerings, customized enterprise solutions, and cloud computing services. Additionally, XYLO earns significant income from consulting and implementation services, helping businesses integrate and optimize their digital infrastructures. Strategic partnerships with leading technology firms enhance XYLO's market reach and product offerings, while ongoing investments in research and development ensure a steady pipeline of innovative solutions that meet evolving customer needs. The company also capitalizes on data analytics and cybersecurity services, which are increasingly in demand as organizations prioritize data-driven decision-making and robust security measures.

Xylo Technologies Ltd Financial Statement Overview

Summary

Xylo Technologies Ltd faces significant financial challenges, characterized by declining revenues, persistent operational losses, and liquidity issues. Despite a positive equity ratio, high leverage and negative cash flows present ongoing risks.

Income Statement

Xylo Technologies Ltd has faced significant challenges in maintaining revenue growth and profitability. The company experienced a notable decline in revenue from 2023 to 2024, with a negative revenue growth rate, and continues to report negative EBIT and net income margins. Despite a consistent gross profit margin, the inability to convert this into positive net income indicates ongoing operational inefficiencies.

Balance Sheet

The company's balance sheet shows a mixed picture. A positive equity ratio reflects a solid capital structure, but the high debt-to-equity ratio indicates potential leverage risks. The declining equity and assets over the years highlight a need for strategic financial management to stabilize the company's financial position.

Cash Flow

Xylo Technologies Ltd has struggled with negative operating and free cash flows, reflecting ongoing liquidity challenges. The company's cash flow from operations remains negative, accentuating the need for improved cash management. However, the reduction in net debt is a positive indicator, suggesting some progress in managing financial obligations.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	57.64M	29.86M	91.72M	91.86M	10.12M	531.00K
Gross Profit	7.80M	6.68M	11.84M	14.45M	4.80M	-503.00K
EBITDA	-5.20M	-7.51M	-12.19M	-5.38M	6.99M	-7.30M
Net Income	-15.99M	-6.03M	-16.02M	-9.81M	6.79M	-4.33M
Balance Sheet
Total Assets	39.29M	37.55M	63.90M	97.65M	59.73M	32.34M
Cash, Cash Equivalents and Short-Term Investments	9.51M	14.67M	12.54M	25.23M	27.34M	22.36M
Total Debt	6.49M	6.86M	9.79M	10.13M	1.62M	107.00K
Total Liabilities	23.37M	19.96M	31.46M	42.96M	8.30M	6.14M
Stockholders Equity	15.19M	17.98M	23.58M	39.14M	49.19M	22.96M
Cash Flow
Free Cash Flow	-4.15M	-1.84M	-7.99M	-5.73M	-10.39M	-6.47M
Operating Cash Flow	-4.11M	-1.82M	-6.25M	-5.66M	-5.25M	-6.14M
Investing Cash Flow	2.73M	2.38M	-4.06M	-4.48M	-12.21M	-1.60M
Financing Cash Flow	-4.27M	-998.00K	-524.00K	5.41M	18.92M	22.95M

Xylo Technologies Ltd Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 4.85
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For XYLO, the sentiment is Negative. The current price of 4.85 is below the 20-day moving average (MA) of 5.02, below the 50-day MA of 5.09, and above the 200-day MA of 4.34, indicating a neutral trend. The MACD of -0.03 indicates Positive momentum. The RSI at 41.68 is Neutral, neither overbought nor oversold. The STOCH value of 21.21 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for XYLO.

Xylo Technologies Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HSCS	54 Neutral	$4.50M	―	-163.47%	―	-100.00%	78.91%
Sector *	52 Neutral	$7.52B	0.25	-63.76%	2.30%	16.15%	0.89%
VERO	47 Neutral	$4.87M	―	-496.27%	―	-16.79%	-3.69%
XYLO	45 Neutral	$3.91M	―	-28.99%	―	-67.77%	66.19%
NUWE	42 Neutral	$783.13K	―	-440.77%	―	-1.21%	93.72%
SINT	42 Neutral	$8.35M	―	-155.20%	―	9.90%	94.56%
RSLS	37 Underperform	$5.68M	―	-120.16%	―	-7.74%	93.25%